남성 골다공증의 위험 요인에 대한 최신 지견과 공중보건학적 중재 전략
An updated finding on the risk factors for osteoporosis in men and public health intervention strategies
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Osteoporosis is a chronic skeletal disease in which the risk of fracture increases due to a decrease in bone strength through a reduction in bone mass and fine structural deterioration of bone tissue. Osteoporosis increases with age and is more common in postmenopausal women, but it is also a major health problem in men. This study presented the latest findings on the risk factors for osteoporosis in men through a literature review and, based on this, suggested public health intervention strategies necessary to prevent and treat osteoporosis in men. Method: We selected and reviewed the 10 most cited papers among 1,453 articles on the risk factors for osteoporosis in men published in PubMed in the last 10 years (2011-2020). Results: The risk factors contributing to the development of osteoporosis in men have been identified as genetic predisposition, lifestyle and diet, alcohol intake and smoking, vitamin D deficiency, lack of physical activity, smoking, sedentary lifestyle, and underweight or obesity. Conclusion: Public health preventive strategies regarding the risk factors for osteoporosis in men require calcium supplementation, increased bone density screening rates, and transparent health communication related to osteoporosis treatment.
Abstract
Objectives: Osteoporosis is a chronic skeletal disease in which the risk of fracture increases due to a decrease in bone strength through a reduction in bone mass and fine structural deterioration of bone tissue. Osteoporosis increases with age and is more common in postmenopausal women, but it is also a major health problem in men. This study presented the latest findings on the risk factors for osteoporosis in men through a literature review and, based on this, suggested public health intervention strategies necessary to prevent and treat osteoporosis in men. Method: We selected and reviewed the 10 most cited papers among 1,453 articles on the risk factors for osteoporosis in men published in PubMed in the last 10 years (2011-2020). Results: The risk factors contributing to the development of osteoporosis in men have been identified as genetic predisposition, lifestyle and diet, alcohol intake and smoking, vitamin D deficiency, lack of physical activity, smoking, sedentary lifestyle, and underweight or obesity. Conclusion: Public health preventive strategies regarding the risk factors for osteoporosis in men require calcium supplementation, increased bone density screening rates, and transparent health communication related to osteoporosis treatment.
참고문헌 (29)
- Robert A Adler, "Osteoporosis in men: a review", Bone Research, 2(1) (2014), Springer Science and Business Media LLC[DOI]
- Bartl, R., "Osteoporosis: Diagnosis, prevention, therapy", pp.253~ (2004), Springer-Verlag Berlin
- Dennis M. Black, "Postmenopausal Osteoporosis", New England Journal of Medicine, 374(3), pp.254~262 (2016), Massachusetts Medical Society[DOI]
- Peggy M. Cawthon, "Gender Differences in Osteoporosis and Fractures", Clinical Orthopaedics & Related Research, 469(7), pp.1900~1905 (2011), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Felicia Cosman, "Romosozumab Treatment in Postmenopausal Women with Osteoporosis", New England Journal of Medicine, 375(16), pp.1532~1543 (2016), Massachusetts Medical Society[DOI]
- F. Cosman, "Clinician’s Guide to Prevention and Treatment of Osteoporosis", Osteoporosis International, 25(10), pp.2359~2381 (2014), Springer Science and Business Media LLC[DOI]
- Steven R. Cummings, "Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis", New England Journal of Medicine, 361(8), pp.756~765 (2009), Massachusetts Medical Society[DOI]
- Howard A. Fink, "Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men", The Journal of Clinical Endocrinology & Metabolism, 91(10), pp.3908~3915 (2006), The Endocrine Society[DOI]
- S Gonnelli, "Obesity and fracture risk", Clinical Cases in Mineral and Bone Metabolism (2014), CIC Edizioni Internazionali[DOI]
- N. C. Harvey, "The role of calcium supplementation in healthy musculoskeletal ageing", Osteoporosis International, 28(2), pp.447~462 (2016), Springer Science and Business Media LLC[DOI]
- Mickael Hiligsmann, "Health Technology Assessment in Osteoporosis", Calcified Tissue International, 93(1), pp.1~14 (2013), Springer Science and Business Media LLC[DOI]
- "Osteoporosis in men" (2017)[URL]
- Alicia R. Jones, "Models of care for osteoporosis: A systematic scoping review of efficacy and implementation characteristics", eClinicalMedicine, 38, pp.101022~ (2021), Elsevier BV[DOI]
- J. A. Kanis, "European guidance for the diagnosis and management of osteoporosis in postmenopausal women", Osteoporosis International, 24(1), pp.23~57 (2012), Springer Science and Business Media LLC[DOI]
- Darya A. Kizub, "Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)", Supportive Care in Cancer, 29(5), pp.2509~2517 (2020), Springer Science and Business Media LLC[DOI]
- Andrew C. Martin, "Osteoporosis in men: A review of endogenous sex hormones and testosterone replacement therapy", Journal of Pharmacy Practice, 24(3), pp.307~315 (2011), SAGE Publications[DOI]
- E. McCloskey, "The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study", Osteoporosis International, 32(2), pp.251~259 (2020), Springer Science and Business Media LLC[DOI]
- Ramin Mohebbi, "Exercise training and bone mineral density in postmenopausal women: an updated systematic review and meta-analysis of intervention studies with emphasis on potential moderators", Osteoporosis International, 34(7), pp.1145~1178 (2023), Springer Science and Business Media LLC[DOI]
- "Osteoporosis, which occurs frequently in women, accounts for 94% of all patients in 2021" (2021)[URL]
- "Bone health and osteoporosis" (2023)[URL]
- "What men need to know" (2021)[URL]
- Socrates Papapoulos, "Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension", Journal of Bone and Mineral Research, 27(3), pp.694~701 (2011), Oxford University Press (OUP)[DOI]
- Salvatore L. Ruggiero, "American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update", Journal of Oral and Maxillofacial Surgery, 72(10), pp.1938~1956 (2014), Elsevier BV[DOI]
- R. G. G. Russell, "Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy", Osteoporosis International, 19(6), pp.733~759 (2008), Springer Science and Business Media LLC[DOI]
- Kenneth G. Saag, "Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis", New England Journal of Medicine, 377(15), pp.1417~1427 (2017), Massachusetts Medical Society[DOI]
- Nader Salari, "The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis", Journal of Orthopaedic Surgery and Research, 16(1) (2021), Springer Science and Business Media LLC[DOI]
- Umberto Tarantino, "Osteoporosis and sarcopenia: the connections", Aging Clinical and Experimental Research, 25(S1), pp.93~95 (2013), Springer Science and Business Media LLC[DOI]
- Roman Thaler, "Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate", Journal of Biological Chemistry, 291(13), pp.6754~6771 (2016), Elsevier BV[DOI]
- Nicole C Wright, "The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine", Journal of Bone and Mineral Research, 29(11), pp.2520~2526 (2014), Oxford University Press (OUP)[DOI]